Anti-herpetic drugs

Q: What is anti-herpetic drugs linked with?

Studies link anti-herpetic drugs with alzheimer's disease drug treatment initiation.

Anti-herpetic drugs has been studied in 1 paper since 2026: 1 observational study in people; 1 in the past year. The newest story, Nov 9, 2026: “Herpes drugs linked to fewer starts of Alzheimer’s treatment”.

Intervention

1 paper studies it1 findingUpdated Jun 15, 2026

See all 1 papers on anti-herpetic drugs

At a glance

The findings reach people, from one lab or study. 1 lab in 1 country.

“Any AHD exposure was associated with 90% reduced hazard of AD treatment (HR 0.09, 95% CI 0.07 to 0.13, p<0.001).”

Association between the use of anti-herpetic drugs and subsequent initiation of Alzheimer's disease drug treatment: Dutch population-based inception cohort studyBMJ open2026doi:10.1136/bmjopen-2025-114033

1 lab in 1 country

Funder: Rijksuniversiteit Groningen

Humans1

What is anti-herpetic drugs linked with?

Studies link anti-herpetic drugs with alzheimer's disease drug treatment initiation.

Alzheimer's disease drug treatment initiation

downin humans1HR 0.09

1 study

Anti-herpetic drugs are linked with a lower risk of alzheimer's disease drug treatment initiation in humans (Dutch population-based cohort) (HR 0.09, 95% CI 0.07 to 0.13, p<0.001).
“Any AHD exposure was associated with 90% reduced hazard of AD treatment (HR 0.09, 95% CI 0.07 to 0.13, p<0.001).”
HumansDutch population-based cohortn = 262,757
Herpes drugs linked to fewer starts of Alzheimer’s treatment
BMJ openJun 15, 2026

Latest

1 paper in 12 months

BMJ OpenJun 16

Herpes drugs linked to fewer starts of Alzheimer’s treatment

Antiviral use was linked to a 90% lower rate of starting Alzheimer’s medication at any given time compared with nonuse.Antiviral use was linked to a 90% lower rate of starting Alzheimer’s medication at any given time compared with nonuse.

Cohort · 262,757 peopleAlzheimer's disease

Paper